Comorbidities are highly prevalent in patients with rheumatoid arthritis (RA), yet clinical care for such patients is often of inferior quality, even in rheumatology clinics. Suggestions for good clinical practice interventions from an expert panel aim to improve the quality of care for patients with RA who have associated comorbidities.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Radner, H. et al. Multimorbidity and rheumatic conditions–enhancing the concept of comorbidity. Nat. Rev. Rheumatol. 10, 252–256 (2014).
Radner, H. et al. Treatment patterns of multimorbid patients with rheumatoid arthritis: Results from an international cross-sectional study. J. Rheumatol. 42, 1099–1104 (2015).
Luque Ramos, A. et al. Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: Results of claims data linked to questionnaire survey. J. Rheumatol. 46, 564–571 (2019).
Kvien, T. K. et al. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities. RMD Open 6, e001211 (2020).
Yoshida, K. et al. The roles of post-diagnosis accumulation of morbidities and lifestyle changes on excess total and cause-specific mortality risk in rheumatoid arthritis. Arthritis Care Res. https://doi.org/10.1002/acr.24120 (2019).
Radner, H., Smolen, J. S. & Aletaha, D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann. Rheum. Dis. 69, 536–541 (2009).
Radner, H. et al. The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Rheumatology 54, 2076–2084 (2015).
Agca, R. et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann. Rheum. Dis. 76, 17–28 (2017).
Baillet, A. et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann. Rheum. Dis. 75, 965–973 (2016).
Calderon-Larranaga, A. et al. Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways. J. Intern. Med. 285, 255–271 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Radner, H. How to improve care for patients with RA and comorbidities. Nat Rev Rheumatol 16, 607–608 (2020). https://doi.org/10.1038/s41584-020-00504-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-00504-y
